INS and neurodegenerative disease: Serum levels of insulin, IGFs and IGF binding proteins (IGFBPs) are altered in human neurodegenerative diseases of various aetiologies, such as Alzheimer’s disease, amyotrophic lateral sclerosis, and cerebellar ataxia [27].